Objective: To evaluate the incidence, risk factors and associated mortality of central lineassociated bloodstream infection (CLABSI) in an adult intensive care unit (ICU) in India. Design: This prospective observational study was conducted over a period of 16 months at a tertiary care referral medical center. Setting: We conducted this study over a period of 16 months at a tertiary care referral medical center. Participants: All patients with a central venous catheter (CVC) for >48 h admitted to the ICU were enrolled. Intervention and main outcome measures: Patient characteristics included were underlying disease, sequential organ failure assessment (SOFA), acute physiology and chronic health evaluation (APACHE II) scores and outcome. Statistical analysis of risk factors for their association with mortality was also done. Results: There were 3235 inpatient-days and 2698 catheter-days. About 46 cases of CLABSI were diagnosed during the study period. The overall rate of CLABSI was 17.04 per 1000 catheter-days and 14.21 per 1000 inpatient-days. The median duration of hospitalization was 23.5 days while the median number of days that a CVC was in place was 17.5. The median APACHE II and SOFA scores were 17 and 10, respectively. Klebsiella pneumoniae was the most common organism (n = 22/55, 40%). Immunosuppressed state and duration of central line more than 10 days were significant factors for developing CLABSI. SOFA and APACHE II scores showed a tendency towards significance for mortality. Conclusions: Our results underscore the need for strict institutional infection control measures. Regular training module for doctors and nurses for catheter insertion and maintenance with a checklist on nurses' chart for site inspection and alerts in all shifts are some measures planned at our center.
Introduction
Critically ill hospitalized patients have a significant risk of developing a nosocomial bloodstream infection (BSI); most of these BSIs are primary and usually originate from an intravascular device [1, 2] . Central line-associated bloodstream infection (CLABSI) rates in intensive care units (ICUs) of developing countries are higher than in the developed world as highlighted in a recent report by the International Nosocomial Infection Control Consortium (INICC). There, it is stated that the pooled rate of CLABSI in the INICC's ICUs, 4.9 per 1000 central line days, is nearly 5-fold higher than the rate reported from comparable US ICUs included in their last report. The INICC study was conducted from January 2007 through December 2012 in 503 ICUs of Latin America, Asia, Africa, and Europe. Using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care-associated infections, the authors collected data from 605 310 patients hospitalized in ICUs during 3 338 396 days [3] . In fact, out of all types of hospital acquired infections, CLABSIs have the highest mortality rate ranging from 12% to 25% [4] . Patients with CLABSIs have increased lengths of hospital stay, higher health care costs and attributable mortality [5] [6] [7] [8] [9] . Moreover in developing countries including India, hospital accreditation is rarely required due to which there is lack of continuous improvement strategies for optimal patient care. Inadequate nurse: patient ratios, unskilled health care providers and open intravenous infusion systems account for the higher incidence of CLABSIs and the subsequent morbidity and mortality in developing countries. Basic infection control measures are also not systematically implemented due to lack of awareness and resources [10] [11] [12] .
The incidence of CLABSI is not only underestimated but also only limited data are available from resource-constraint countries like India. The aim of this study therefore was to evaluate the incidence, risk factors and associated mortality of nosocomial CLABSI in an adult ICU in northern India over a period of 16 months.
Methods

Setting
This prospective observational study was conducted in the medical ICU of Sanjay Gandhi Postgraduate Institute of Medical Sciences, a 900 bed tertiary referral medical center in northern India. The medical ICU has 12 beds and 5 intensivists with 9 nurses per 8 h shift. The study protocol was approved by the ethics committee of the Institute.
Data collection and analysis of risk factors
All patients with central venous catheters (CVCs) for >48 h admitted to the ICU were enrolled for the study. Data were collected from January 2014 to April 2015. A senior resident extracted patient data prospectively from charts. Written and informed consent were obtained from each patient. The medical records of patients were retrieved from the Hospital Information System. The demographic and clinical characteristics included were age, gender, underlying disease or diagnosis, sequential organ failure assessment (SOFA), acute physiology and chronic health evaluation (APACHE II) scores, exposure to antibiotics within previous 1 month and outcome.
All patients included in this study were analyzed for various risk factors. Host related risk factors included diabetes mellitus and immune-suppression (defined as receiving systemic steroids, i.e. prednisolone at either 2 mg/kg of body weight or a total of 20 mg/day or equivalent for at least 3 months or drugs used for transplantation, neutropenia). Health care-associated factors included duration of hospitalization and invasive procedure, if any (such as CVC, Foley's catheter or endotracheal tube). These factors were dichotomized and analyzed for their potential role in predicting the risk for developing CLABSI and its attributable mortality.
The central lines if inserted at some other health care facility or ward were changed at admission to our ICU within 48 h. The insertion and maintenance was done according to the central line care bundle approach [13] . All central line insertions were done in upper limb and lower limb was used only in case of emergency. Transparent dressings were used for maintenance. Guide wire exchange was not practiced.
Definitions
CLABSI was defined as a primary laboratory confirmed bacteremia or fungemia if a recognized pathogen was cultured from one or more percutaneous blood cultures after 48 h of vascular catheterization, and the pathogen cultured from blood was not related to an infection at another site. With common skin commensals (e.g. diphtheroids, Bacillus spp., Propionibacterium spp., coagulasenegative staphylococci or micrococci), the organism was cultured from 2 or more blood cultures drawn on separate occasions [14] .
Culture techniques, identification and antimicrobial susceptibility testing
During the study a total of 861 blood samples were collected in BACTEC culture vials (Becton Dickinson, NJ, USA) in the Department of Critical Care Medicine and processed in the Bacteriology section of the Department of Microbiology [15, 16] . All isolates were identified manually and sensitivity was determined by Kirby Bauer disc diffusion method. Minimal inhibitory concentrations to Imipenem and Meropenem in Gram-negative isolates were also determined by E-test (bioMe´rieux, Craponne, France). Where needed, identification and susceptibility were confirmed by Phoenix System, BD Diagnostics (Becton Dickinson and Company). The control strains used for all susceptibility tests were Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923. Results were interpreted as per Clinical and Laboratory Standards Institute guidelines, 2015 [17] .
Statistical analysis
Statistical analysis was performed using the statistical package for social sciences (SPSS Version 20.0, SPSS, Chicago, Il, USA). All continuous data are presented as median with inter quartile range. Categorical variables are summarized using proportions and percentages. All significant variables in the univariate analysis were included in a logistic-regression model to identify the risk factors associated with CLABSI. Univariate analysis was also done to identify the risk factors associated with mortality in patients with CLABSI. A P value < 0.05 was considered statistically significant.
Results
During the16-month study period, a total of 153 patients were admitted to the ICU and 112 patients (73.2%) had multiple catheter insertions. The overall catheter utilization rate was 83.4%; 129 cases were from the medical unit and 24 cases were from the surgical unit. About 46 cases of CLABSI were diagnosed during the study period.
There were 3235 inpatient-days and 2698 catheter-days. The overall rate of CLABSI was 17.04 per 1000 catheter-days and 14.21 per 1000 inpatient-days.
The clinical and demographic characteristics along with risk factors of all patients admitted to the ICU as well as cases diagnosed with CLABSI are shown in Table 1 . A review of the potential predisposing factors in all cases revealed that 31% patients had diabetes mellitus, 28% had hypertension, 10% had chronic obstructive pulmonary disease (COPD), 9% had coronary artery disease while 5% were immune-suppressed.
The median number of blood cultures sent was 5 (range 2-8). A total of 55 microorganisms were recovered out of which Klebsiella pneumoniae (n = 22, 40%) was the most common isolate. Other Gram-negative pathogens included five isolates each of Pseudomonas aeruginosa and Acinetobacter species (9%), Stenotrophomonas maltophilia (n = 3, 5.4%), Proteus species (n = 2, 3.6%) and one isolate each of Pantoea agglomerans, Sphingobacterium maltivorum and Porphyromonas species. Gram-positive isolates included S. aureus (n = 4) and Enterococcus species (n = 5). Out of these two were methicillin resistant Staphylococcus aureus, while one isolate each of vancomycin resistant Enterococcus faecium and Enterococcus faecalis was recovered. Candida species were isolated from five cases.
Univariate analysis of associated co-morbidities for the potential risk of CLABSI is shown in Table 2 . The risk factors significantly associated with higher probability of developing CLABSI were immunosupression, age more than 60 years, duration of central line more than 10 days and length of stay in ICU more than 21 days. Multivariate analysis of risk factors showed that an immunosuppressed state and duration of central line more than 10 days were independent predictors of acquiring CLABSI ( Table 3) .
The overall mortality in this study was 46% (71/153). CLABSI associated mortality was 56% (26/46). Results of univariate analysis for predictors of mortality in patients who developed CLABSI are shown in Table 4 . SOFA and APACHE II scores showed an association with higher mortality.
Discussion
Critically ill patients often require central venous access for the administration of fluids, medicines and blood products, and as such they are more prone to develop bloodstream infections [2] . Our study, though single center, is relevant since data from India on CLABSI in an ICU setup is scarce. The severity of illness and comorbidities in our patients were considerably higher than that reported from other centers [1, 3, 13] , which was the probable reason of a very high catheter utilization rate (>80%). We have a baseline CLABSI rate of 17.04 per 1000 catheter-days which is nearly 16-fold higher than in the USA [4, 18] . We also made an attempt to obtain baseline data on all ICU admissions during the study period to plan interventions and optimize patient management. Several studies have proved that central lines are associated with a considerable risk of infection, increased length of hospital stay, excess costs and an increased attributable mortality. Rello et al. in a study on the evaluation of outcome of intravenous catheter-related infections in critically ill patients concluded that these infections led to an increased length of hospital stay by 20 days and each episode of central line infection represented an additional cost of more than 3000 Euros [19] . Higuera et al. and Wilson et al. confirmed similar findings in subsequent trials both in adult as well as pediatric populations [20, 21] .
Analyses of various risk factors to determine their association with acquisition of CLABSI showed that diabetes mellitus, immunesuppression, age more than 60 years, duration of central line days more than 10 and length of stay in ICU more than 21 days were significantly associated with development of CLABSI. On multivariate analysis immune-suppression and central line days more than 10 were independently associated with development of CLABSI. Callister et al. in a case control study on risk factors for CLABSIs in the era of prevention bundles had shown that in bivariate analysis, CLABSI was associated with female sex, triple lumen catheters, total parenteral nutrition as the insertion indication, number of laboratory tests, number of intravenous medications given in the day prior to CLABSI diagnosis and number of line days [22] .
Multidrug resistant organisms in our hospital setting accounted for more than 80% of the organisms recovered with 100% of Gram-negative isolates being extended spectrum beta-lactamase producers. Indiscriminate antimicrobial therapy without establishing the etiology of infection eradicates susceptible Gram-positive cocci resulting in selection of resistant Gram-negative bacilli. All K. pneumoniae isolates recovered in this study except one were carbapenem resistant. We also recovered two colistin resistant K. pneumoniae strains which highlights the alarming rate of multidrug resistance. This could have contributed to the high mortality (14/22, 63.6%) seen in patients with K. pneumoniae sepsis.
In several recent studies performed worldwide especially conducted by INICC it has been shown that applying multidisciplinary infection control measures can effectively control CLABSI rates. This includes hand hygiene, maximal sterile barriers upon catheter insertion, use of chlorhexidine gluconate for skin preparation and avoidance of the femoral vein for access site as well as education, outcome and process surveillance [13, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] .
However, CLABSI continues to be a threat to patient safety even in the prevention bundle era. Worldwide most centers are attempting to follow these bundles but despite their use, CLABSI cases are still reported implicating the presence of certain other risk factors. Callister et al. showed catheter duration to be an important risk which is also highlighted in our study. Therefore, apart from insertion bundle strict maintenance bundles should also be implemented [22, 26] .
Conclusion
The results of our study are important for patient management and underscore the need for an institutional infection control committee to effectively implement and sustain the bundle approach as well as develop antibiotic treatment policies. We at our center are planning to start regular training module for doctors and nurses for catheter insertion and maintenance with a checklist on nurses' chart for site inspection and alerts for doctors in all shifts.
This study has several limitations-first, we conducted this investigation at a single institution; therefore, our findings may not be generalized to other hospitals in India. Second, the study was conducted during a short period of 16 months and therefore the numbers of cases were few. Lastly and the most important is that we did not conduct a before-after surveillance or collect data after any intervention that could result in reduction of CLABSI rates.
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